Lechner, Matt, Fjaeldstad, Alexander, Rehman, Umar, Liu, Jacklyn, Boniface, David, Boardman, Jim, Boak, Duncan, Altundag, Aytug, Frasnelli, Johannes, Gane, Simon, Holbrook, Eric, Hsieh, Julien, Huart, Caroline, Konstantinidis, Iordanis, Landis, Basile N., Lund, Valerie J., Macchi, Alberto, Mori, Eri, Mueller, Christian, Mullol, Joaquim, Negoias, Simona, Patel, Zara M., Pinto, Jayant M., Poletti, Sophia, Ramakrishnan, Vijay, Rombaux, Philippe, Vodicka, Jan, Welge-Luessen, Antje, Whitcroft, Katherine L., Yan, Carol, Philpott, Carl and Hummel, Thomas (2025) The development and validation of the Smell-Qx questionnaire, based on a systematic review of the literature and the COMET initiative on the development of core outcome sets for clinical trials in olfactory disorders. International Forum of Allergy & Rhinology. ISSN 2042-6976
Full text not available from this repository. (Request a copy)Abstract
Background: Olfactory dysfunction affects up to 22% of the population. Accurate assessment is vital for diagnosis and tracking outcomes, often using patient-reported outcome measures (PROMs). Aims: We aimed to develop and validate a novel questionnaire for assessing olfactory and gustatory dysfunction. Methods: A systematic review identified existing smell and taste questionnaires, followed by item generation and selection. After two Delphi cycles and consultation with a large panel of smell and taste experts, the Smell-Qx questionnaire was developed. A validation study recruited patients from smell and taste clinics (cases) and general ENT clinics (controls) to complete the Smell-Qx. Additionally, patients with smell and taste disorders underwent psychophysical testing using Sniffin' Stick Threshold, Discrimination, and Identification (TDI) tests. Results: The Smell-Qx is an 11-domain instrument, with five core domains used for total score calculation and six history/quality-of-life domains for obtaining a comprehensive history. The validation study recruited 60 participants (32 patients with smell/taste disorders and 28 controls). Items showed acceptable to significant internal consistency (Cronbach's α: 0.64?0.97) and test-retest reliability (ICC: 0.65?0.99, p < 0.001). The Smell-Qx was effective at distinguishing patients with smell and taste disorders from controls (t = 9.99, df = 58, p < 0.0001). Concurrent criterion validity was good with overall SATD-related quality of life (r = 0.43, p = 0.015), as well as with the smell loss domain and overall smell TDI scores (r = ?0.54, p = 0.011). Conclusion: The Smell-Qx is a reliable and valid PROM for assessing olfactory and self-reported gustatory disorders, capturing symptom severity and quality-of-life impact. It can integrate into a multi-modal assessment approach alongside psychophysical testing.
Item Type: | Article |
---|---|
Additional Information: | Data Availability Statement: The data that support the findings of this study are available from the corresponding author upon reasonable request. Funding: The authors received no specific funding for this work. |
Uncontrolled Keywords: | gustatory dysfunction,olfactory dysfunction,patient-reported outcome measures |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health Faculty of Medicine and Health Sciences > Research Groups > Respiratory and Airways Group |
Depositing User: | LivePure Connector |
Date Deposited: | 09 May 2025 16:30 |
Last Modified: | 09 May 2025 16:30 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/99234 |
DOI: | 10.1002/alr.23604 |
Actions (login required)
![]() |
View Item |